Cargando…

A drug use survey among clients of harm reduction sites across British Columbia, Canada, 2012

BACKGROUND: In British Columbia (BC), understanding of high-risk drug use trends is largely based on survey and cohort study data from two major cities, which may not be representative of persons who use drugs in other regions. Harm reduction stakeholders, representing each of the five geographic he...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuo, Margot, Shamsian, Arash, Tzemis, Despina, Buxton, Jane A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4016659/
https://www.ncbi.nlm.nih.gov/pubmed/24766846
http://dx.doi.org/10.1186/1477-7517-11-13
_version_ 1782315544334041088
author Kuo, Margot
Shamsian, Arash
Tzemis, Despina
Buxton, Jane A
author_facet Kuo, Margot
Shamsian, Arash
Tzemis, Despina
Buxton, Jane A
author_sort Kuo, Margot
collection PubMed
description BACKGROUND: In British Columbia (BC), understanding of high-risk drug use trends is largely based on survey and cohort study data from two major cities, which may not be representative of persons who use drugs in other regions. Harm reduction stakeholders, representing each of the five geographic health regions in BC, identified a need for data on drug use to inform local and regional harm reduction activities across the province. The aims of this project were to (1) develop a drug use survey that could be feasibly administered at harm reduction (HR) sites across all health regions and (2) assess the data for differences in reported drug use frequencies by region. METHODS: A pilot survey focusing on current drug use was developed with stakeholders and administered among clients at 28 HR supply distribution sites across the province by existing staff and peers. Data were collated and analysed using univariate and bivariate descriptive statistics to assess differences in reported drug use frequencies by geography. A post-survey evaluation was conducted to assess acceptability and feasibility of the survey process for participating sites. RESULTS: Crack cocaine, heroin, and morphine were the most frequently reported drugs with notable regional differences. Polysubstance use was common among respondents (70%) with one region having 81% polysubstance use. Respondents surveyed in or near their region's major centre were more likely to report having used crack cocaine (p < 0.0001) and heroin (p < 0.0001) in the past week as compared to those residing >50 km from the major centre. Participants accessing services >50 km from the regional centre were more likely to have used morphine (p < 0.0001). There was no difference in powder cocaine use by client/site proximity to the regional centre. Participating sites found the survey process acceptable, feasible to administer annually, and useful for responding to client needs. CONCLUSIONS: The survey was a feasible way for harm reduction sites across BC to obtain drug use data from clients who actively use drugs. Drug use frequencies differed substantially by region and community proximity to the regional centre, underlining the need for locally collected data to inform service planning.
format Online
Article
Text
id pubmed-4016659
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-40166592014-05-11 A drug use survey among clients of harm reduction sites across British Columbia, Canada, 2012 Kuo, Margot Shamsian, Arash Tzemis, Despina Buxton, Jane A Harm Reduct J Research BACKGROUND: In British Columbia (BC), understanding of high-risk drug use trends is largely based on survey and cohort study data from two major cities, which may not be representative of persons who use drugs in other regions. Harm reduction stakeholders, representing each of the five geographic health regions in BC, identified a need for data on drug use to inform local and regional harm reduction activities across the province. The aims of this project were to (1) develop a drug use survey that could be feasibly administered at harm reduction (HR) sites across all health regions and (2) assess the data for differences in reported drug use frequencies by region. METHODS: A pilot survey focusing on current drug use was developed with stakeholders and administered among clients at 28 HR supply distribution sites across the province by existing staff and peers. Data were collated and analysed using univariate and bivariate descriptive statistics to assess differences in reported drug use frequencies by geography. A post-survey evaluation was conducted to assess acceptability and feasibility of the survey process for participating sites. RESULTS: Crack cocaine, heroin, and morphine were the most frequently reported drugs with notable regional differences. Polysubstance use was common among respondents (70%) with one region having 81% polysubstance use. Respondents surveyed in or near their region's major centre were more likely to report having used crack cocaine (p < 0.0001) and heroin (p < 0.0001) in the past week as compared to those residing >50 km from the major centre. Participants accessing services >50 km from the regional centre were more likely to have used morphine (p < 0.0001). There was no difference in powder cocaine use by client/site proximity to the regional centre. Participating sites found the survey process acceptable, feasible to administer annually, and useful for responding to client needs. CONCLUSIONS: The survey was a feasible way for harm reduction sites across BC to obtain drug use data from clients who actively use drugs. Drug use frequencies differed substantially by region and community proximity to the regional centre, underlining the need for locally collected data to inform service planning. BioMed Central 2014-04-27 /pmc/articles/PMC4016659/ /pubmed/24766846 http://dx.doi.org/10.1186/1477-7517-11-13 Text en Copyright © 2014 Kuo et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Kuo, Margot
Shamsian, Arash
Tzemis, Despina
Buxton, Jane A
A drug use survey among clients of harm reduction sites across British Columbia, Canada, 2012
title A drug use survey among clients of harm reduction sites across British Columbia, Canada, 2012
title_full A drug use survey among clients of harm reduction sites across British Columbia, Canada, 2012
title_fullStr A drug use survey among clients of harm reduction sites across British Columbia, Canada, 2012
title_full_unstemmed A drug use survey among clients of harm reduction sites across British Columbia, Canada, 2012
title_short A drug use survey among clients of harm reduction sites across British Columbia, Canada, 2012
title_sort drug use survey among clients of harm reduction sites across british columbia, canada, 2012
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4016659/
https://www.ncbi.nlm.nih.gov/pubmed/24766846
http://dx.doi.org/10.1186/1477-7517-11-13
work_keys_str_mv AT kuomargot adrugusesurveyamongclientsofharmreductionsitesacrossbritishcolumbiacanada2012
AT shamsianarash adrugusesurveyamongclientsofharmreductionsitesacrossbritishcolumbiacanada2012
AT tzemisdespina adrugusesurveyamongclientsofharmreductionsitesacrossbritishcolumbiacanada2012
AT buxtonjanea adrugusesurveyamongclientsofharmreductionsitesacrossbritishcolumbiacanada2012
AT kuomargot drugusesurveyamongclientsofharmreductionsitesacrossbritishcolumbiacanada2012
AT shamsianarash drugusesurveyamongclientsofharmreductionsitesacrossbritishcolumbiacanada2012
AT tzemisdespina drugusesurveyamongclientsofharmreductionsitesacrossbritishcolumbiacanada2012
AT buxtonjanea drugusesurveyamongclientsofharmreductionsitesacrossbritishcolumbiacanada2012